Leaderboards/antiplatelet therapy and cardiovascular diseases

antiplatelet therapy and cardiovascular diseases

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Faizan Mazhar
Karolinska Institutet
99
2
Juan Jesús Carrero
Danderyds sjukhus
90
3
Mattía Galli
Maria Cecilia Hospital
80
4
Tobias Feige
Düsseldorf University Hospital
70
5
Dominick J. Angiolillo
Florida College
50
6
Dario Bongiovanni
Humanitas University
20

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Roger E. G. Schutgens
Utrecht University
90
2
Tamer A. Addissouky
Alrafidain University College
80
3
Silvia Grimaldi
University of Pisa
70
4
Margarita-Ioanna Koufaki
University of Patras
40
5
Kilian Kirmes
TUM Klinikum
30
6
Shuo Zhang
Nanchang University
30
7
Sibi N Krishnamurthy
University of Miami
20
8
Zainali Chunawala
The University of Texas Southwestern Medical Center
10

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Harvey D. White
Littelfuse (United States)
99
2
Liliana Laranjo
The University of Sydney
99
3
Eric J. Topol
Case Western Reserve University
90
4
Tiziano Barbui
University of Bergamo
80
5
Alberto Zanchetti
University of Milano-Bicocca
70
6
Margitta Elvers
Düsseldorf University Hospital
60
7
Michael B. Fallon
University of Arizona
60
8
Jennifer A. Rymer
Duke University
60
9
Luigi Di Biase
Albert Einstein College of Medicine
50
10
Paul A. Gurbel
Sinai Hospital
50

All-Time Leaders Papers

1
Long COVID: major findings, mechanisms and recommendations
Nature Reviews Microbiology|2023
4k cit.
2
Conversational agents in healthcare: a systematic review
Journal of the American Medical Informatics Association|2018
1.3k cit.
3
1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee.
Hypertension|1993
1.2k cit.
4
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
Leukemia|2013
666 cit.
5
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Blood Cancer Journal|2018
632 cit.
6
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study
Blood|2019
34 cit.
7
Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet–Mediated Amyloid Aggregation in Alzheimer’s Disease
International Journal of Molecular Sciences|2021
29 cit.
8
Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients
Diabetes Care|2011
25 cit.
9
Cangrelor Use Patterns and Transition to Oral P2Y <sub>12</sub> Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry
Journal of the American Heart Association|2022
21 cit.
10
Collagen receptor GPVI-mediated platelet activation and pro-coagulant activity aggravates inflammation and aortic wall remodelling in abdominal aortic aneurysm
bioRxiv (Cold Spring Harbor Laboratory)|2023
2 cit.

Reagents for antiplatelet therapy and cardiovascular diseases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

Vimentin (D21H3) Rabbit Monoclonal Antibody (APC Conjugate)

Cited in 5 papers
#95159$465
View Evidence →Cell Signaling Technology

Histone H2A.X (D17A3) Rabbit Monoclonal Antibody (BSA and Azide Free)

#24533$865
View Evidence →Cell Signaling Technology

Phospho-Stat5 (Tyr694) (D47E7) Rabbit Monoclonal Antibody (SignalFlex™ Pacific Blue™ Conjugate)

#23382$486
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Sox2 (L73B4) Mouse Monoclonal Antibody

Cited in 6 papers
#4195$158
View Evidence →Cell Signaling Technology

Phospho-AMPK beta1 (Ser182) Antibody

Cited in 6 papers
#4186$362
View Evidence →Cell Signaling Technology

SIK3 Antibody

Cited in 5 papers
#39477$317
View Evidence →